JPRN-UMIN000007031已完成未知
Safety of the pandemic influenza A(H5N1) vaccination (Kaketsuken) on 1,000 healthy adult volunteers and it's effectiveness if H5N1 influenza was spread. - Safety of the Influenza A(H5N1) vaccination on 1,000 healthy volunteers (H5N1_KD safety)
Clinical Research Center, National Hospital Organization0 个研究点目标入组 1,000 人开始时间: 2012年1月10日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 1,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Individuals with the history of Swine Influenza A (H5N1) virus infection. (obtained from subjects) 2) Individuals, who had history of anaphylaxis to foods or medicines previously. 3) Individuals with severe diseases in cardiovascular, blood, respiratory, liver, kidney, digestive or neurological systems in their clinical recording. 4) Individuals with a history of acute disseminated encephalomyelitis and Guillain-Barre syndrome in the past. 5) Individuals participated in a clinical trial within four months (counted from the date of vaccination). 6) Individuals vaccinated with live vaccine within 27 days, or received a dose of inactivated vaccine within six days (including the day of vaccination). 7) Individuals received with gamma globulin or blood transfusion within three months, or received the formulation of high dose of gamma globulin therapy (200 mg/kg or more) within six months (including the day of vaccination). 8)Individuals who are deemed to be inappropriate by the investigator
研究者
相似试验
已完成
不适用
Safety of the pandemic influenza A (H5N1) vaccination of Egyptian stain on 1,000 healthy adult volunteers and it's effectiveness if H5N1 influenza might be spread.Prevention of influenzaJPRN-UMIN000011816Clinical Research Center, National Hospital Organization1,000
进行中（未招募）
不适用
Efficacy of the H1N1 Flu (swine flu) vaccination in patients with Rheumatoid Arthritis treated with rituximabTo assess the efficacy of A/H1N1 vaccination in patients treated with rituximab therapyEUCTR2009-016789-10-NLDiv KIR AMC
已完成
不适用
Efficacy and safety of the pandemic influenza A(H5N1) vaccination on whether the sequential hetero-strains vaccination would provide wide range of immunogenicity, and whether single-shot vaccination would develop effective priming.JPRN-UMIN000007027Clinical Research Center, National Hospital Organization300
尚未招募
不适用
Efficacy and effectiveness of influenza vaccine and pneumococcal conjugated vaccine - 13 (PCV13) in patients with chronic kidney diseaseInfluenza vaccine13-valent pneumococcal vaccinechronic kidney diseaseschronic kidney diseasepneumoniaTCTR20160609002Queen Saovabha Memorial Institute, the Thai Redcross society1,584
已完成
不适用
Efficacy and safety of vaccination of the influenza A (H5N1) Egyptian strain, and searching for the optimal intervals of the primary vaccination.Prevention of influenzaJPRN-UMIN000011799Clinical Research Center, National Hospital Organization140